1
Reactions 1444 - 23 Mar 2013 The UK MHRA has launched a self-directed learning package for clinical practitioners, outlining the risks associated with benzodiazepines. The continuing professional development (CPD)-approved learning module is intended to be used by doctors, nurses and pharmacists caring for individuals who might need treatment with a benzodiazepine. It discribes the main features of adverse effects, factors that increase their risk, how risk can be reduced and specific treatment for adverse effects. The module accompanies similar CPD-approved modules on the safe use of SSRIs, opioids and antipsychotics. MHRA. Learning package on benzodiazepines launched. Internet Document : 12 Mar 2013. Available from: URL: http://www.mhra.gov.uk 803084640 1 Reactions 23 Mar 2013 No. 1444 0114-9954/10/1444-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

MHRA launches CPD learning module on benzo safety

  • Upload
    ngonhu

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Page 1: MHRA launches CPD learning module on benzo safety

Reactions 1444 - 23 Mar 2013

■ The UK MHRA has launched a self-directedlearning package for clinical practitioners, outliningthe risks associated with benzodiazepines. Thecontinuing professional development (CPD)-approvedlearning module is intended to be used by doctors,nurses and pharmacists caring for individuals whomight need treatment with a benzodiazepine. Itdiscribes the main features of adverse effects, factorsthat increase their risk, how risk can be reduced andspecific treatment for adverse effects. The moduleaccompanies similar CPD-approved modules on thesafe use of SSRIs, opioids and antipsychotics.MHRA. Learning package on benzodiazepines launched. Internet Document :12 Mar 2013. Available from: URL: http://www.mhra.gov.uk 803084640

1

Reactions 23 Mar 2013 No. 14440114-9954/10/1444-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved